Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chafic Karam

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Multiple Sclerosis and Related Disorders|March 15, 2019
Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosisNarupat Suanprasert, Bruce V Taylor, Christopher J Klein, et al.
Journal of Health Economics and Outcomes Research|June 30, 2025
Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Multifocal Motor Neuropathy: A US Claims Database Cohort StudyNikhil Khandelwal, Marie Sanchirico, Ade Ajibade, et al.
Muscle & Nerve|January 4, 2017
Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosisSabrina Paganoni, Eric A Macklin, Chafic Karam, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2015
Vasculitic neuropathy following exposure to minocyclineJohn M Baratta, P James B Dyck, Patricio Brand, et al.
Expert Review of Clinical Pharmacology|July 4, 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosisMorie A Gertz, Morton Scheinberg, Márcia Waddington-Cruz, et al.
Neurology and Therapy|August 6, 2021
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTRAaron Yarlas, Andrew Lovley, Kristen McCausland, et al.
Frontiers in Neurology|February 16, 2026
Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United StatesCécile Blein, Chafic Karam, Clémence Arvin-Berod, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 30, 2024
PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation studyOle B Suhr, Martha Grogan, Ana Martins da Silva, et al.
International Journal of Molecular Sciences|April 13, 2024
Neurofilament Light Chains in Systemic Amyloidosis: A Systematic ReviewMilou Berends, Hans L A Nienhuis, David Adams, et al.
Neurology|July 31, 2012
Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALSColin Quinn, Lauren Elman, Leo McCluskey, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Multiple Sclerosis and Related Disorders|March 15, 2019
Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosisNarupat Suanprasert, Bruce V Taylor, Christopher J Klein, et al.
Journal of Health Economics and Outcomes Research|June 30, 2025
Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Multifocal Motor Neuropathy: A US Claims Database Cohort StudyNikhil Khandelwal, Marie Sanchirico, Ade Ajibade, et al.
Muscle & Nerve|January 4, 2017
Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosisSabrina Paganoni, Eric A Macklin, Chafic Karam, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2015
Vasculitic neuropathy following exposure to minocyclineJohn M Baratta, P James B Dyck, Patricio Brand, et al.
Expert Review of Clinical Pharmacology|July 4, 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosisMorie A Gertz, Morton Scheinberg, Márcia Waddington-Cruz, et al.
Neurology and Therapy|August 6, 2021
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTRAaron Yarlas, Andrew Lovley, Kristen McCausland, et al.
Frontiers in Neurology|February 16, 2026
Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United StatesCécile Blein, Chafic Karam, Clémence Arvin-Berod, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 30, 2024
PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation studyOle B Suhr, Martha Grogan, Ana Martins da Silva, et al.
International Journal of Molecular Sciences|April 13, 2024
Neurofilament Light Chains in Systemic Amyloidosis: A Systematic ReviewMilou Berends, Hans L A Nienhuis, David Adams, et al.
Neurology|July 31, 2012
Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALSColin Quinn, Lauren Elman, Leo McCluskey, et al.
Pageof 12